Effectiveness of the polyenzymic drug preparation WOBE-MUGOS E in lymphoproliferative diseases

Kolomoets M.Yu., Antofiychuk M. P.(Chernovtsy)

Likarska sprava – vrachebnoe delo 1999, No.  4, pp. 150 – 154

Czech abstract, Russian abstract

The drug Wobe-Mugos E was prescribed to patients with chronic lymphoid leukosis and multiple myeloma during and following the administration of chemotherapy treatments, 3 tablets on a three-times daily schedule 30 to 45 minutes before meals for 2 to 4 weeks. A positive effect was manifested by improvement in morphofunctional properties of erythrocytes, detoxycating and antioxidant effects. There were no cases of intolerability or side effects of the drug in the examined patients.